Monash tests show strong cardioprotective qualities for Algorae drug candidate
Algorae Pharmaceutical Ltd has completed preclinical tests on its drug candidate for heart disease, AI-168
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results